Oppenheimer & Co’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Hold
8,973
﹤0.01% 1616
2026
Q1
$215K Buy
+8,973
New +$219K ﹤0.01% 1545
2023
Q3
Sell
-11,398
Closed -$115K 1400
2023
Q2
$115K Sell
11,398
-3,055
-21% -$28.4K ﹤0.01% 1347
2023
Q1
$136K Sell
14,453
-1,875
-11% -$22.1K ﹤0.01% 1305
2022
Q4
$200K Sell
16,328
-1,989
-11% -$24.8K ﹤0.01% 1230
2022
Q3
$227K Sell
18,317
-4,019
-18% -$70.3K 0.01% 1168
2022
Q2
$438K Sell
22,336
-4,203
-16% -$99.5K 0.01% 965
2022
Q1
$692K Sell
26,539
-50
-0.2% -$1.33K 0.01% 881
2021
Q4
$755K Buy
26,589
+8,934
+51% +$278K 0.01% 892
2021
Q3
$563K Hold
17,655
0.01% 966
2021
Q2
$612K Buy
17,655
+1,080
+7% +$35.6K 0.01% 935
2021
Q1
$488K Sell
16,575
-540
-3% -$16.6K 0.01% 974
2020
Q4
$525K Sell
17,115
-6,775
-28% -$207K 0.01% 867
2020
Q3
$667K Sell
23,890
-2,572
-10% -$65.2K 0.02% 714
2020
Q2
$568K Buy
+26,462
New +$585K 0.01% 761
2020
Q1
Sell
-7,082
Closed -$209K 1227
2019
Q4
$209K Buy
+7,082
New +$192K 0.01% 1159
2019
Q2
Sell
-17,198
Closed -$552K 1324
2019
Q1
$552K Buy
+17,198
New +$529K 0.01% 778

Other funds holding ELAN

Oppenheimer & Co's ELAN Position: Q2 2026 in Review

Oppenheimer & Co held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 8,973 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Oppenheimer & Co first reported a position in ELAN in Q1 2019 and has held it in 17 quarters since. The position peaked at $755K in Q4 2021. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Oppenheimer & Co held 8,973 shares of Elanco Animal Health worth $221K as of Q2 2026.
  • Oppenheimer & Co left its Elanco Animal Health share count unchanged in Q2 2026.
  • Elanco Animal Health made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1616 holding.
  • Oppenheimer & Co first reported a position in Elanco Animal Health in Q1 2019 and has held it in 17 quarters since.
  • Oppenheimer & Co's Elanco Animal Health position peaked at $755K in Q4 2021.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.